Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis
- PMID: 29404775
- DOI: 10.1007/s00330-017-5222-0
Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis
Abstract
Objectives: To examine the evidence regarding the effectiveness and safety of endovascular interventional modalities for haemorrhage control in abnormal placentation deliveries.
Methods: MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to July 2017. Blood loss volume was regarded as the primary endpoint. Other important results are described. Random and fixed effects models were used for the meta-analysis.
Results: Of 385 studies identified, 69 (1,811 patients, mean age 32.9 years, range 23-39 years) were included. Mean gestational age at delivery was 35.1 weeks (range 27-38 weeks). Of 1,395 patients who underwent endovascular intervention, 587 (42%) had placenta accreta, 254 (18%) placenta increta and 313 (22%) placenta percreta. Prophylactic balloon occlusion of the internal iliac arteries (PBOIIA) was performed in 470 patients (33.6%), of the abdominal aorta (PBOAA) in 460 patients (33%), of the uterine artery (PBOUA) in 181 patients (13%), and of the common iliac arteries (PBOCIA) in 21 patients (1.5%). Primary embolization of the UA was performed in 246 patients (18%), of the pelvic collateral arteries in 12 patients (0.9%), and of the anterior division of the IIA in 5 patients (0.3%). Follow-up ranged from 0.5 to 42 months. Endovascular intervention was associated with less blood loss than no endovascular intervention (p < 0.001) with the lowest blood loss volume in patients who underwent PBOAA (p < 0.001). PBOAA was associated with a lower rate of hysterectomy (p = 0.030). Endovascular intervention did not result in increases in operative time or hospital stay.
Conclusions: Endovascular intervention is effective in controlling haemorrhage in abnormal placentation deliveries. PBOAA was associated with a lower rate of hysterectomy and less blood loss than other modalities.
Key points: • Endovascular intervention in abnormal placentation deliveries is effective in reducing blood loss. • Endovascular intervention did not result in longer operative time or hospital stay. • Prophylactic balloon occlusion of the abdominal aorta is superior to other modalities.
Keywords: Balloon occlusion; Endovascular procedures; Haemorrhage; Placenta accreta; Uterine artery embolization.
Similar articles
-
Clinical evaluation of the effect for prophylactic balloon occlusion in pregnancies complicated with placenta accreta spectrum disorder: A systematic review and meta-analysis.Int J Gynaecol Obstet. 2024 Oct;167(1):109-127. doi: 10.1002/ijgo.15704. Epub 2024 Jun 20. Int J Gynaecol Obstet. 2024. PMID: 38899567
-
Expanding the field of acute care surgery: a systematic review of the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) in cases of morbidly adherent placenta.Eur J Trauma Emerg Surg. 2018 Aug;44(4):519-526. doi: 10.1007/s00068-017-0840-4. Epub 2017 Sep 19. Eur J Trauma Emerg Surg. 2018. PMID: 28929283
-
Prophylactic internal Iliac artery balloon occlusion in placenta accreta spectrum: evaluating efficacy, risks, and clinical implications.BMC Pregnancy Childbirth. 2025 Jul 3;25(1):721. doi: 10.1186/s12884-025-07842-3. BMC Pregnancy Childbirth. 2025. PMID: 40610997 Free PMC article.
-
Prophylactic Radiologic Interventions for Postpartum Hemorrhage Control in Women With Placenta Accreta Spectrum Disorder: A Systematic Review and Meta-analysis.Obstet Gynecol. 2024 Sep 1;144(3):315-327. doi: 10.1097/AOG.0000000000005662. Epub 2024 Jul 2. Obstet Gynecol. 2024. PMID: 38954828 Free PMC article.
-
Efficacy and safety of prophylactic abdominal aortic balloon occlusion versus internal iliac arterial balloon occlusion for placenta accreta spectrum disorder: A systematic review and meta-analysis.Clin Imaging. 2021 Oct;78:250-255. doi: 10.1016/j.clinimag.2021.06.020. Epub 2021 Jun 18. Clin Imaging. 2021. PMID: 34171597
Cited by
-
Successful treatment of total placenta previa by multidisciplinary therapy in a Jehovah's Witness patient who refused blood transfusions.BMJ Case Rep. 2018 Nov 8;2018:bcr2018226486. doi: 10.1136/bcr-2018-226486. BMJ Case Rep. 2018. PMID: 30413456 Free PMC article.
-
Placenta Accreta Spectrum Outcomes Using Tourniquet and Forceps for Vascular Control.Front Med (Lausanne). 2021 Oct 18;8:557678. doi: 10.3389/fmed.2021.557678. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34733857 Free PMC article.
-
Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis.BMC Pregnancy Childbirth. 2019 Jan 15;19(1):30. doi: 10.1186/s12884-019-2175-0. BMC Pregnancy Childbirth. 2019. PMID: 30646863 Free PMC article.
-
Role of Abdominal Aortic Balloon Placement in Planned Conservative Management of Placenta Previa With Placenta Increta or Percreta.Front Med (Lausanne). 2021 Dec 14;8:767748. doi: 10.3389/fmed.2021.767748. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34970561 Free PMC article.
-
Efficacy and safety of prophylactic balloon occlusion in the management of placenta accreta spectrum disorder: a retrospective cohort study.BMC Womens Health. 2024 Apr 1;24(1):208. doi: 10.1186/s12905-024-03049-4. BMC Womens Health. 2024. PMID: 38561713 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources